Invention Grant
- Patent Title: Use of immunomodulatory protein from ganoderma in inhibiting cancer stem cells
-
Application No.: US14982519Application Date: 2015-12-29
-
Publication No.: US09937226B2Publication Date: 2018-04-10
- Inventor: Cheng-Chia Yu
- Applicant: MYCOMAGIC BIOTECHNOLOGY CO., LTD
- Applicant Address: TW New Taipei
- Assignee: MYCOMAGIC BIOTECHNOLOGY CO., LTD.
- Current Assignee: MYCOMAGIC BIOTECHNOLOGY CO., LTD.
- Current Assignee Address: TW New Taipei
- Agency: WPAT, P.C., Intellectual Property Attorneys
- Agent Anthony King
- Main IPC: A61K38/16
- IPC: A61K38/16 ; C07K14/37 ; C07K14/375 ; A61K45/06
Abstract:
The present invention relates to a new use of an immunomodulatory protein derived from Ganoderma or a recombinant or a composition thereof in inhibiting cancel stem cells. Particularly, the immunomodulatory protein is derived form Ganoderma microsporum and the cancel stem cell is oral cancer stem cell.
Public/Granted literature
- US20160184389A1 USE OF IMMUNOMODULATORY PROTEIN FROM GANODERMA IN INHIBITING CANCER STEM CELLS Public/Granted day:2016-06-30
Information query
IPC分类:
